These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 658123)

  • 1. Haloperidol depresses the accumulation of apomorphine in the striatum of the rat.
    Vetulani J; Melzacka M; Wiszniowska G
    Eur J Pharmacol; 1978 May; 49(1):117-8. PubMed ID: 658123
    [No Abstract]   [Full Text] [Related]  

  • 2. Haloperidol-induced changes in the regional cerebral pharmacokinetics of apomorphine.
    Melzacka M; Wiszniowska G; Daniel W; Vetulani J
    Pol J Pharmacol Pharm; 1979; 31(4):387-91. PubMed ID: 523341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
    Friend WC; Brown GM; Jawahir G; Lee T; Seeman P
    Am J Psychiatry; 1978 Jul; 135(7):839-41. PubMed ID: 665797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of haloperidol and apomorphine on the K+-depolarized overflow of [3H] dopamine from rat striatal slices.
    Miller JC; Friedhoff AJ
    Biochem Pharmacol; 1979 Mar; 28(5):688-90. PubMed ID: 444255
    [No Abstract]   [Full Text] [Related]  

  • 5. Monosialoganglioside increased the in vivo affinity of D2 receptors for apomorphine in supersensitive rats.
    Vital MB; Frussa-Filho R; Palermo-Neto J
    Ann N Y Acad Sci; 1998 Jun; 845():428-9. PubMed ID: 9668390
    [No Abstract]   [Full Text] [Related]  

  • 6. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y; Komori T; Okuda S; Segawa T
    Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of noncholinergic drugs on rat striatal acetylcholine levels.
    McGeer PL; Grewaal DS; McGeer EG
    Brain Res; 1974 Nov; 80(2):211-7. PubMed ID: 4154064
    [No Abstract]   [Full Text] [Related]  

  • 8. Apomorphine increases glucose utilization in the substantia nigra, subthalamic nucleus and corpus striatum of rat.
    Brown LL; Wolfson LI
    Brain Res; 1978 Jan; 140(1):188-93. PubMed ID: 626883
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine receptors and cholinergic neurons in the rat neostriatum.
    Guyenet PG; Javoy F; Agid Y; Beaujouan JC; Glowinski J
    Adv Neurol; 1975; 9():43-51. PubMed ID: 238376
    [No Abstract]   [Full Text] [Related]  

  • 10. Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity.
    Raiteri M; Cerrito F; Casazza G; Levi G
    Adv Biochem Psychopharmacol; 1980; 24():37-43. PubMed ID: 7405669
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of apomorphine-induced inhibition of striatal dopamine-turnover following chronic haloperidol.
    Gianutsos G; Hynes MD; Lal H
    Biochem Pharmacol; 1975 Mar; 24(5):581-2. PubMed ID: 1125062
    [No Abstract]   [Full Text] [Related]  

  • 12. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
    Ichikawa J; Meltzer HY
    Brain Res; 1990 Jan; 507(1):138-42. PubMed ID: 2302571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
    Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding.
    Fujita N; Saito K; Hirata A; Iwatsubo K; Noguchi Y; Yoshida H
    Brain Res; 1980 Oct; 199(2):335-42. PubMed ID: 7417787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical and striatal in vivo uptake and metabolism of plasma choline in the rat: effects of haloperidol and apomorphine.
    Aquilonius SM; Eckernäs SA
    Acta Pharmacol Toxicol (Copenh); 1976 Jul; 39(1):129-40. PubMed ID: 988965
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat.
    Lai HC; Carino MA; Horita A
    Proc West Pharmacol Soc; 1981; 24():5-6. PubMed ID: 6114496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.